HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?

Item
http://www.wikidata.org/entity/Q38174260
AASLD guidelines for treatment of chronic hepatitis B.Antiviral therapies and prospects for a cure of chronic hepatitis B.Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapyLamivudine-resistant rtL180M and rtM204I/V are persistently dominant during combination rescue therapy with entecavir and adefovir for hepatitis B.New paradigms in hepatitis B management: only diamonds are forever.Nucleos(t)ide analogues for the prevention of hepatitis B recurrence after liver transplantation do not affect serum phosphorus levels.TG1050, an immunotherapeutic to treat chronic hepatitis B, induces robust T cells and exerts an antiviral effect in HBV-persistent mice.Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?
P2860

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues?

Item
http://www.wikidata.org/entity/Q38174260
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
type
label
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
prefLabel
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698
P356
P1433
P1476
HBeAg-negative chronic hepatit ...... with nucleos(t)ide analogues?
@en
P2093
P2860
P304
P31
P356
P478
P50
P577
P5875
P698